Segment Information (Tables)

9 Months Ended

Sep. 30, 2016

Segment Reporting [Abstract]

Selected financial info by reportable segment

Selected financial information by reportable segment is presented below (in thousands).

	Three Months Ended September 30,						Nine Months Ended September 30,
	2016			2015			2016			2015
Revenues, net:
Prescription Pharmaceuticals	$	268,880		$	240,995		$	784,644		$	657,611
Consumer Health	15,215			15,806			48,532			47,488
Total revenues, net	284,095			256,801			833,176			705,099
Gross Profit:
Prescription Pharmaceuticals	163,300			155,242			482,427			397,330
Consumer Health	6,927			7,770			22,590			24,252
Total gross profit	170,227			163,012			505,017			421,582
Operating expenses	83,399			72,245			238,242			191,446
Operating income	86,828			90,767			266,775			230,136
Other expense	(11,614		)	(16,752		)	(44,714		)	(47,435		)
Income before income taxes	$	75,214		$	74,015		$	222,061		$	182,701